Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Amarantus Bioscience Holdings Inc. (AMBS) had Income from Continuous Operations of $-25.21M for the most recently reported fiscal year, ending 2015-12-31.
| Income Statement Financials | |
-- |
|
$-37.06M |
|
-- |
|
-- |
|
$24.82M |
|
$-24.82M |
|
$-0.39M |
|
$-25.21M |
|
$-25.21M |
|
$-25.21M |
|
|
Income from Continuous Operations |
$-25.21M |
$-25.21M |
|
$-25.21M |
|
$-24.82M |
|
$-23.16M |
|
8.88M |
|
8.88M |
|
$-4.17 |
|
$-4.17 |
|
| Balance Sheet Financials | |
$0.83M |
|
$0.12M |
|
$10.94M |
|
$11.77M |
|
$16.19M |
|
-- |
|
$1.11M |
|
$17.30M |
|
$-17.45M |
|
$-16.36M |
|
$-5.53M |
|
21.18M |
|
| Cash Flow Statement Financials | |
$-16.01M |
|
$-4.91M |
|
$20.89M |
|
$0.21M |
|
$0.18M |
|
$-0.04M |
|
$2.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
-- |
|
-0.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
144.47% |
|
154.10% |
|
-214.20% |
|
455.62% |
|
$-0.26 |
|
$-1.80 |
|
$-1.80 |
|